A COMBINED VIRTUAL SCREENING OF COMPOUNDS FROM CARICA PAPAYA LEAVES AGAINST THE SARS-CORONAVIRUS-2 PROTEIN TARGET

Authors

  • SHANNON IAN FERNANDES Department of Biotechnology, NMAM Institute of Technology, Nitte, Karnataka, India.

DOI:

https://doi.org/10.22159/ijms.2022.v10i6.46619

Keywords:

Carica papaya, Coronavirus, Severe acute syndrome-Cov-2, Main protease, Auto-docking, Screening, ADMET analysis, Drug, Phytocompounds

Abstract

Objective: The coronavirus known as severe acute respiratory syndrome (SARS)-Cov-2 was a new strain that had generated a pandemic that was spreading due to an increase in cases and fatalities. Coronavirus causes respiratory and intestinal infections in animals and humans and accounted for the highest number of fatalities during the pandemic research. Numerous research focused on developing supplementary therapy that alleviates the symptoms and addresses comorbidities.

Methods: In the present study, we examined the outcomes of an in silico investigation to develop a novel oral medication against the SARS coronavirus. In this investigation, chemicals from Carica papaya leaves, which have been suggested as an herbal remedy for main protease (Mpro) inhibitor of SARS-Coronavirus-2, were subjected to an integrated virtual screening. The chosen substances were then subjected to pharmacological and toxicological screening. Finally, the screening was carried out by docking the chosen compound against the protein target of SARS-Coronavirus-2 using Biovia and PyRx.

Results: Docking studies identified myristoleic acid, palmitic acid, and thiamine as effective therapeutic agents against Mpro of SARS-Coronavirus-2.

Conclusion: It is worthwhile to suggest C. papaya leaves for additional in vitro research against SARS-Coronavirus-2 at both the molecular and cellular levels.

References

Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-92.

Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol 2021;74:168-84.

Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: History, mechanism, transmission, structural studies and therapeutics. Infection 2021;49:199-213.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265-9.

Hegyi A, Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J Gen Virol 2002;83:595-9.

Yang H, Xie W, Xue X, Yang K, Ma J, Liang W, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 2005;3:e324.

Ji Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020;582:289-93.

Hariyono P, Patramurti C, Candrasari DS, Hariono M. An integrated virtual screening of compounds from Carica papaya leaves against multiple protein targets of SARS-Coronavirus-2. Results Chem 2021;3:100113.

Da Silva JA, Rashid Z, Nhut DT, Sivakumar D, Gera A, Souza MT, et al. Papaya (Carica papaya L.) biology and biotechnology. Tree Forest Sci Biotechnol 2007;1:47-73.

Yogiraj V, Goyal PK, Chauhan CS, Goyal A, Vyas B. Carica papaya Linn: An overview. Int J Herbal Med 2014;2:1-8.

Behzadi P, Gajdács M. Worldwide protein data bank (wwPDB): A virtual treasure for research in biotechnology. Eur J Microbiol Immunol (Bp) 2021;11:77-86.

Zappa M, Verdecchia P, Spanevello A, Angeli F. Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines. Eur J Intern Med 2022;104:33-6.

Laskowski RA. PDBsum new things. Nucleic Acids Res 2009;37:D355-9.

Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand R, Aparna SR, Mangalapandi P, et al. IMPPAT: A curated database of indian medicinal plants, phytochemistry and therapeutics. Sci Rep 2018;8:4329.

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Res 2021;49:D1388-95.

Sakshuwong S, Weir H, Raucci U, Martínez TJ. Bringing chemical structures to life with augmented reality, machine learning, and quantum chemistry. J Chem Phys 2022;156:204801.

Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.

Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021;49:W5-14.

Stork C, Mathai N, Kirchmair J. Computational prediction of frequent hitters in target-based and cell-based assays. Artif Intell Life Sci 2021;1:100007.

Fareed MM, El-Esawi MA, El-Ballat EM, Batiha GE, Rauf A, El-Demerdash FM, et al. In silico drug screening analysis against the overexpression of PGAM1 gene in different cancer treatments. BioMed Res Int 2021;2021:5515692.

Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015;1263:243-50.

Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020;85:104502.

Cohen PA, Hall LE, John JN, Rapoport AB. The early natural history of SARS-CoV-2 infection: Clinical observations from an urban, ambulatory COVID-19 clinic. Mayo Clin Proc 2020;95:1124-6.

Fiorino S, Tateo F, De Biase D, Gallo CG, Orlandi PE, Corazza I, et al. SARS-CoV-2: Lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol 2021;16:1105-33.

Zhong N, Zhang S, Zou P, Chen J, Kang X, Li Z, et al. Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. J Virol 2008;82:4227-34.

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science 2020;368:409-12.

Hilgenfeld R. From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 2014;281:4085-96.

Singh SP, Kumar S, Mathan SV, Tomar MS, Singh RK, Verma PK, et al. Therapeutic application of Carica papaya leaf extract in the management of human diseases. Daru 2020;28:735-44.

Vij T, Prashar Y. A review on medicinal properties of Carica papaya Linn. Asian Pac J Trop Dis 2015;5:1-6.

Jo S, Kim S, Shin DH, Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 2020;35:145-51.

Luporini RL, Pott-Junior H, Leal MC, Castro A, Ferreira AG, Cominetti MR, et al. Phenylalanine and COVID-19: Tracking disease severity markers. Int Immunopharmacol 2021;101:108313.

Holeček M. Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond) 2018;15:33.

Wu GY, Field CJ, Marliss EB. Elevated glutamine metabolism in splenocytes from spontaneously diabetic BB rats. Biochem J 1991;274:49-54.

Newsholme P, Curi R, Curi TC, Murphy CJ, Garcia C, de Melo MP. Glutamine metabolism by lymphocytes, macrophages, and neutrophils: Its importance in health and disease. J Nutr Biochem 1999;10:316-24.

Zhang H, Chen Y, Li Y, Zhang T, Ying Z, Su W, et al. l-Threonine improves intestinal mucin synthesis and immune function of intrauterine growth-retarded weanling piglets. Nutrition. 2019;59:182–7.

Comai S, Bertazzo A, Brughera M, Crotti S. Tryptophan in health and disease. Adv Clin Chem 2020;95:165-218.

Holeček M. Serine metabolism in health and disease and as a conditionally essential amino acid. Nutrients 2022;14:1987.

Published

16-11-2022

How to Cite

FERNANDES, S. I. (2022). A COMBINED VIRTUAL SCREENING OF COMPOUNDS FROM CARICA PAPAYA LEAVES AGAINST THE SARS-CORONAVIRUS-2 PROTEIN TARGET. Innovare Journal of Medical Sciences, 10(6), 25–32. https://doi.org/10.22159/ijms.2022.v10i6.46619

Issue

Section

Original Article(s)